Osteonecrosis News and Research

RSS
Medication use and doctor visits drive up jaw necrosis-related costs

Medication use and doctor visits drive up jaw necrosis-related costs

Perthes’ disease link to congenital disorders revealed

Perthes’ disease link to congenital disorders revealed

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Caltech-led team discovers enzyme responsible for neural crest cell development

Caltech-led team discovers enzyme responsible for neural crest cell development

Bisphosphonates increase risk for bone disease after tooth extraction

Bisphosphonates increase risk for bone disease after tooth extraction

New JEBDP series provides updates on evidence-based care in periodontics and implant dentistry

New JEBDP series provides updates on evidence-based care in periodontics and implant dentistry

Age at onset influences juvenile dermatomyositis course

Age at onset influences juvenile dermatomyositis course

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Simple interventions boost vertebral fracture osteoporosis care

Simple interventions boost vertebral fracture osteoporosis care

Radiotherapy redundant in low-risk Hodgkin lymphoma treatment

Radiotherapy redundant in low-risk Hodgkin lymphoma treatment

Bisphosphonate benefit for breast cancer yet to be proven

Bisphosphonate benefit for breast cancer yet to be proven

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Women with spine fractures can benefit from alendronate therapy

Women with spine fractures can benefit from alendronate therapy

FDA issues Complete Response Letter to Amgen’s sBLA for XGEVA

FDA issues Complete Response Letter to Amgen’s sBLA for XGEVA

Merck wins New Jersey FOSAMAX litigation

Merck wins New Jersey FOSAMAX litigation

Maturitas publishes EMAS' clinical guide on SERMs against postmenopausal osteoporosis

Maturitas publishes EMAS' clinical guide on SERMs against postmenopausal osteoporosis

Cartilage graft can stimulate bone regeneration

Cartilage graft can stimulate bone regeneration

FDA panel votes against Amgen’s Xgeva in prostate cancer

FDA panel votes against Amgen’s Xgeva in prostate cancer